NBNataliya Balatska

Nataliya Balatska

*This is an algorithmically generated author record based on publicly available information.

Nataliya Balatska has a total of 32 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Scurvy in children: literature review and a clinical case of severe scurvy in a 5-year-old child of psycho-social genesis

    by N.I. Balatska, A.M. Antoshkina, Ya.S. Stepaniuk, A.G. Rusyn, S.M. Rudenko

    In children, scurvy is characterized by pronounced musculoskeletal symptoms; it can mimic rheumatological, vascular, and oncological diseases and often leads to a prolonged diagnostic process. Aim - to identify key anamnestic, clinical, and imaging features essential for the timely diagnosis of scurvy, based on a literature review and the clinical course of the disease in a preschool-aged child. Clinical case. A girl aged 5 years and 9 months was examined in hospitals of various levels of care during three months with different preliminary diagnoses: reactive coxitis, acute popliteal vein thrombosis, tumor process in the thigh, dermatomyositis, and neurofibromatosis. The main clinical manifestation was thickening of the lower extremities: the thighs, shins, and joints, with signs of inflammation (soft-tissue induration, local hyperemia and hyperthermia, severe pain). The child was malnourished, lost the ability to stand and walk, and the limbs assumed a "frog legs" position. Laboratory tests indicated an inflammatory process and deficiency states (vitamins D and B12, and folate). Imaging studies revealed changes typical of scurvy, but specialists, due to limited experience, interpreted them as consistent with another pathology. A detailed analysis of the patient's diet indicated a likely vitamin C deficiency; extremely low serum vitamin C levels confirmed the diagnosis. Treatment of multivitamin deficiency was effective. Conclusions. Knowledge of the clinical presentation of scurvy in children and typical paraclinical findings, combined with attention to dietary history and the family environment-particularly during times of social disasters (epidemics, wars) - will contribute to the timely diagnosis of scurvy. The study was conducted in accordance with the Declaration of Helsinki. The child's parents provided informed consent for the child to participate in the study. The authors declare no conflict of interest.

  • Open Access

    ANCA-associated nephritis in children: current perspectives on diagnosis and treatment strategies (literature review)

    by T.V. Budnik, M.V. Khaitovych, N.I. Balatska

    Background. ANCA-associated vasculitis in children is considered an orphan disease; however, renal involvement manifested as rapidly progressive glomerulonephritis determines the patient’s survival prognosis and the risk of end-stage renal disease. The purpose was to review scientific research and updated international protocols regarding the genetic determinacy, mechanisms of pauci-immune injury, diagnosis, and treatment of ANCA-associated nephritis in children. Materials and methods. The literature review was based on the analysis of scientific research results available in open access, using information retrieval systems such as PubMed, Web of Science, Scopus, Google Scholar, and ResearchGate. Sixty scientific papers, primarily published within the last 5 years, were reviewed in accordance with the selected topic and study objective. Results. The review details the 2012 Chapel Hill Consensus Conference nomenclature and genetic predisposition to ANCA-associated vasculitis (the role of HLA-DP and HLA-DQ loci). The primary diagnostic significance of detecting antibodies to proteinase-3 (PR3-ANCA) and myeloperoxidase (MPO-ANCA) via enzyme-linked immunosorbent assay is substantiated, demonstra­ting high specificity for the verification of granulomatosis with polyangiitis and microscopic polyangiitis, respectively. The specificity of “renal masks” and extrarenal manifestations (ENT pathology, alveolar hemorrhages) is described. Differential diagnosis with anti-glomerular basement membrane disease and immune complex nephritis is provided. The shift in the treatment paradigm based on the PEXIVAS trial evidence and the new KDIGO 2024 guidelines is highlighted: a strategy for rapid glucocorticoid load minimization (down to 5 mg/day by the 12th week) to preserve the child’s growth potential is substantiated. Particular attention is focused on the priority of rituximab as a steroid-sparing agent and the role of the Berden histological classification in predicting renal survival. An algorithm for pediatrician actions in cases of suspected rapidly progressive glomerulonephritis is substantiated. Conclusions. Early diagnosis verification using enzyme-linked immunosorbent assay for PR3/MPO antibodies and kidney biopsy according to KDIGO 2024 criteria is crucial. The implementation of targeted biological therapy and low-dose steroid regimens improves patients’ quality of life and reduces the incidence of disability.

  • Open Access

    The role of dual-energy X-ray absorptiometry in the detection of secondary skeletal involvement in a female patient with Gardner syndrome and HIV infection

    by Maksym Sytor, Mykyta Nechaiev, Nataliya Balatska, Oksana Kozlova, Kateryna Ruzhylo

    Gardner syndrome is a rare genetic disorder, considered a phenotypic variant of familial adenomatous polyposis, which is associated with an aberration in the adenomatous polyposis coli (APC) gene. It is characterized by a combination of intestinal (colonic polyps) and a wide spectrum of extracolonic manifestations, including osteomas, desmoid tumors, epidermal cysts, hypertrophy of the retinal pigment epithelium, follicular thyroid cancer, and others. This article describes a clinical case of atypical bone changes in a female patient with Gardner syndrome, HIV infection, chronic post-hemorrhagic anemia, and hypothyroidism in a state of medical compensation. Gardner syndrome was confirmed at the age of three by endoscopic and morphological examination of multiple adenomatous polyps in the esophagus, stomach, duodenum, and colon. HIV infection was diagnosed at the age of 13.5 years, for which the girl receives antiretroviral therapy (ART). At the age of 17, she was referred for dual-energy X-ray absorptiometry (DXA), which revealed areas of localized increased bone mineral density in the projection of the upper third of the skull bilaterally. Subsequent skull radiography in the anteroposterior projection identified these changes as pronounced bilateral hyperostosis, while magnetic resonance imaging (MRI) of the brain further visualized diffuse thickening of the skull bones, emphasized at the vault level, with no pathological changes in the brain parenchyma. Thus, the detected hyperostosis had no clear clinical manifestations but became an incidental diagnostic finding during a routine dual-energy X-ray absorptiometry scan. The described case also illustrates the need for a multidisciplinary approach to managing patients with comorbid pathologies, as only the collaboration of doctors from different specialties allows for the correct interpretation of the results and determination of the optimal tactics for further examination and treatment. The detected hyperostosis in an adolescent with HIV infection and Gardner syndrome may likely be attributed to severe chronic anemia, which may have both diagnostic and prognostic significance. This case highlights the potential utility of X-ray absorptiometry that can serve not only as a method for quantitative assessment of bone mineral density but also as an additional tool for detecting skeletal structural changes that require further verification using other diagnostic imaging methods.

  • Open Access

    Bone health in children and adolescents: impact of risk factors and modern preventive strategies

    by H.V. Beketova, O.V. Sharikadze, N.I. Balatska

    Background. Bone health is the condition of bone tissue determined by genetic, environmental, hormonal, nutritional and mechanical influences, which ensures its resistance to fractures; it is the basis of the effective implementation of extraskeletal and mechanical functions of the skeleton, an important component of the harmonious development of children and adolescents and their overall physical well-being throughout life. The purpose was to review scientific research on the effects of micronutrients and physical activity on bone mineral density in children and adolescents and identify strategies for preventing bone health disorders. Materials and methods. The literature review was based on the analysis of the results of scientific research published in the open access using the information search systems PubMed, Web of Science, Scopus, Google Scholar and ResearchGate. One hundred and nine scientific papers published mostly in the last 5 years were reviewed in accordance with the chosen topic and research objective. Results. The literature review suggests that bone health depends on a number of factors. Among the controllable factors, an important role belongs to maintaining a healthy lifestyle, in particular, sufficient physical activity, the absence of bad habits, optimal nutrition, balanced primarily in terms of essential micronutrients such as calcium and vitamin D. Insufficient calcium and vitamin D intake in childhood and, especially, in adolescence (a critical period for bone growth and development) is accompanied by a decrease in the efficiency of bone mineral density formation and reaching its optimal peak, which increases the risk of develo­ping a number of chronic diseases, osteoporosis, and bone fractures in adults. ­Conclusions. To prevent bone health disorders and reduce the global impact of diseases related to them, modern stra­tegies have been developed, including educational and information technologies, programs to enrich staple foods with essential micronutrients, lifestyle changes, early detection, timely intervention and monitoring of calcium and vitamin D deficiency, creation of appropriate digital health tools and personalized approaches to nutrition.

  • Open Access

    Bone mineral density in non-ambulatory adolescents with Duchenne muscular dystrophy living in Ukraine

    by Ya.S. Stepaniuk, N.I. Balatska, N.V. Grygorieva, A.M. Antoshkina, А.S. Musiіenko, T.O. Shkliarska, M.B. Kozelkova

    Background. The study focuses on bone mineral density (BMD) evaluation in non-ambulatory adolescents with Du­chenne muscular dystrophy (DMD). DMD is a progressive muscle destruction, which leads to complete mobility loss and death. The pathogenic mechanisms of the disease, long-term use of glucocorticoids and progressive immobility cause the subsequent involvement of bone tissue, leading to osteopenia and secondary osteoporosis and, as a result, pathological fractures of various locations and, therefore, require prevention, early diagnosis, and treatment. The purpose was to assess bone mineral density and the frequency of osteoporosis in non-ambulatory patients with DMD. Materials and methods. Thirteen male patients aged 11–18 years with DMD from different regions of Ukraine were examined. Medical histories were reviewed for glucocorticoid treatment (including daily dose), vitamin D and calcium supplementation, the history of bone fractures and their location. Anthropometric data were collected, including height and body mass index assessment. All patients had a consultation with an endocrinologist. Bone tissue parameters were evaluated at the level of the lumbar spine, entire skeleton, right proximal femur, right femoral neck by dual-energy X-ray absorptiometry using Hologic Discovery Wi scanner. Serum levels of ionized calcium, 25(OH)D, and parathyroid hormone were also measured. Results. Eleven (84.6 %) patients had low BMD; osteoporosis was diagnosed in 38.5 % of them. 69.2 % were undergoing glucocorticoid therapy, with an average daily dose of 24.50 ± 5.38 mg. Additionally, most patients (61.5 %) had low levels of 25(OH)D. Conclusions. The high frequency of low bone mineral density among patients with Duchenne muscular dystrophy highlights the necessity for regular dual-energy X-ray absorptiometry and monitoring serum 25(OH)D levels, particularly for those on glucocorticoid therapy.

  • Open Access

    Congenital spondyloepiphyseal dysplasia due to COL2A1 gene mutation

    by Kyiv Si Ukrainian Center Of Мaternity And Childhood Of The Nams Of Ukraine, O.M. Mukvich, L.I. Omelchenko, N.I. Balatska, D.M. Sarakhman, T.A. Liudvik, A.O. Yakovenko

    Skeletal dysplasia is a rare genetic pathology that is a consequence of disorders of osteo-, chondrogenesis and other changes in the development and growth of epiphyseal cartilage, epiphyses, metaphyses, diaphyses of long bones and vertebral bodies, which leads to dysfunction of peripheral joints and spine in children. Aim - to familiarize with the features of the course, clinical manifestations and diagnosis of spondyloepiphyseal dysplasia (SED) with osteoarthritis and progressive osteoporosis in childhood. A clinical case of own observation of a child of adolescent age with complaints of difficulty walking, rapid fatigue, limping, starting pain in the joints, back during the day, limitation of function of the knee, hip, shoulder, elbow, radiocarpal joints, cervical spine, contractures of the elbow, radiocarpal joints is presented. In the presence of typical signs of the SED phenotype (short stature, specific facial features, rapid fatigue, limping, starting pain in the joints, back during the day, limitation of function of the knee, hip, shoulder, elbow, radiocarpal joints, cervical spine, contractures of the elbow, radiocarpal joints), no extraskeletal manifestations were detected in the child. During molecular genetic testing, a heterozygous variant in the COL2A1 gene (p.611G>A (p.Gly204Asp)) was identified in the patient, which is associated with bone disease and is characterized by the development of generalized osteoarthritis and systemic osteoporosis. Conclusions. Congenital spondyloepiphyseal dysplasia in childhood can occur under the guise of rheumatic diseases without obvious laboratory activity of the inflammatory process and early development of contractures, stiffness in the joints and progressive osteoporosis. Patients require a comprehensive examination using modern laboratory, instrumental and genetic examination methods and careful differential diagnosis and involvement of a multidisciplinary team of specialists for the management of such patients. The study was performed in accordance with the principles of the Declaration of Helsinki. Informed consent of the child's parents was obtained for the study. The authors declare that there is no conflict of interest.

  • Open Access

    Clinical features of 5-year-old girl with 22q11.2 deletion syndrome in a 5-year-old girl. To the 60th anniversary of the first description of DiGeorge syndrome

    by A.M. Antoshkina, N.I. Balatska

    Since the article is devoted to the 60th anniversary of the definition of DiGeorge syndrome, it describes the biographical data of pediatric endocrinologist A.M. DiGeorge, the essential aspects of the syndrome's study, the main clinical presentation and diagnosis. Aim - to reflect A.M. DiGeorge's important contribution to the current understanding of the syndrome and present a personal clinical observation of a child with 22q11.2 deletion syndrome. Clinical case. A 5-year-old girl had such clinical symptoms as heart defects – multiple ventricular septal defects (Ø 10 mm perimembranous defect and Ø 2 mm apical muscular defect), secondary atrial septal defect, and high arterial hypertension; thymus aplasia was accompanied by moderate lymphopenia, reduced T-lymphocyte level, and decreased IgG level during the first two years of life (frequent viral respiratory diseases clinically manifested immunodeficiency); craniofacial dysmorphism; low levels of parathyroid hormone with normal levels of calcium in the blood; delayed speech development, dysarthria; cognitive deficit of mild degree. The diagnosis was confirmed by the FISH method. The peculiarities of the child's development and her laboratory and instrumental results are given in the dynamics of five years. Conclusions. Over the past 60 years, there has been a significant transformation in the understanding of DiGeorge syndrome, which has gone from a congenital endocrine disease and primary immunodeficiency to a chromosomal anomaly (22q11.2 chromosome deletion syndrome) with multiorgan dysfunction. Nowadays, such patients need multidisciplinary and personalized management. The study was conducted in accordance with the principles of the Helsinki Declaration. Informed consent was obtained from the patients for conducting the study. The authors declare no conflict of interest.

  • Open Access

    Dermatosparaxis type of Ehlers-Danlos syndrome: case report

    by N.I. Balatska, O.A. Stroi, I.V. Grynevych, P.V. Husynin, O.P. Medvedieva, K.YU. Kyrylchuk

    Background. The dermatosparaxial type of Ehlers-Danlos syndrome (EDSDERMS, VIIC, dEDS) is an extremely rare disorder. To date, 15 patients with this type of Ehlers-Danlos syndrome are known worldwide. The purpose was to improve knowledge and spread data about the orphan connective tissue di­sease — dEDS — on the example of a patient from a family in which the father and two sons have the same type of lesions. Materials and methods. We report a 6-year-old patient as well as his father and sibling with clinical symptoms of the dEDS, which we diagnosed based on the main diagnostic criteria: extreme skin fragi­lity, craniofacial features, superficial skin trauma, wrinkling of the palms, especially when they are exposed to water for a long time, and a tendency to ecchymosis with a risk of subcutaneous hematomas and bleeding. Secondary diagnostic criteria were represen­ted by atrophic scars, refractive errors (myopia), gingival margi­nal dysplasia, hypermobility of the finger and knee joints. The informed consent of the patient’s parents was obtained for the exa­mination and publication of information, and the parents agreed to the publication of clinical photographs. Results. After laboratory and instrumental studies and consultations with related specialists (hematologist, geneticist, cardiologist, pediatrician, orthopedist, dermatologist), we excluded such diseases as Marfan syndrome, MASS-phenotype, congenital coagulopathies and thrombocytopathies, hemophilia, isolated vascular pathologies, as well as other types of Ehlers-Danlos syndrome and identified dEDS in the patient only clinically. Genetic testing did not reveal any pathological mutations or exonic deletions/duplications. The negative result of genetic testing in dEDS is due to the fact that certain types of mutations (e.g., deep intronic mutations) cannot always be detec­ted by standard diagnostic genetic methods. Conclusions. It is possible to establish a diagnosis based on clinical symptoms, but an extended mutation search is mandatory for the entire family.

  • Clinical case of alopecia totalis in pediatric practice

    by O.а. Stroi, Т.а. Кyian, N.I. Balatska, L.O. Levadna, G.E. Kozynkevych


  • Open Access

    Возрастные особенности изменений минеральной плотности костной ткани у мальчиков донецкого региона

    by V.V. Povoroznyuk, F.V. Klymovytsky, N.I. Balatska

    С помощью двухэнергетического денситометра Discovery QPR (Bedford, США) проведено обследование 79 мальчиков одной из общеобразовательных школ Донецка. Изучались показатели телосложения (обезжиренная масса, жировая масса и процент жировой массы), ИМТ, а также МПКТВС, МПКТПП и МПКТБК. При исследовании МПКТ на уровне всего скелета, поясничного отдела позвоночника и проксимального отдела левой бедренной кости был отмечен рост этого показателя с увеличением возраста мальчиков. Установлено, что с возрастом прогрессивно растут показатели телосложения детей, в частности показатели обезжиренной и жировой массы. Установлено, что антропометрические характеристики достоверно изменяются с увеличением возраста мальчиков. Зато ИМТ обследованных детей не зависел от возраста. Возраст достоверно влияет на вариабельность показателей минеральной плотности костной ткани и телосложения у мальчиков разного возраста. Особенности изменений в телосложении обследованных детей характеризовались тем, что у мальчиков в 13–16 лет наблюдаются достоверно высокие показатели обезжиренной массы (p < 0,01–0,001).